Hemostats Market Size, Share Report, Analysis, Trends, Growth 2032

The global Hemostats market size accrued earnings worth approximately USD 2.72 Billion in 2023 and is predicted to gain revenue of about USD 4.33 Billion by 2032, is set to record a CAGR of nearly 5.40% over the period from 2024 to 2032.

Request Free Sample

Global Hemostats Market: Overview

The hemostat is also known as arterial forceps or hemostatic clamp. It is a surgical tool that is used during major surgical procedures in order to control blood loss or halt bleeding during surgery. It is basically used in the early phases of surgery for an initial incision that closes blood vessels until ligation. Hemostats consist of a group of instruments that include pivot, tissue holders, needle holders, and various clamps. Reduce blood loss by hemostasis is the major challenge in any surgery. It can be achieved by various methods such as flowable and sealants, mechanical methods, active agents, thermal energy based devices, topical hemostatic agents, pharmaceutical agents, and thermal energy based devices. This procedure ensures strong adhesion of wound edges, rapid cessation of blood loss, tight sealing, prompt closure, reduced scarring, rapid healing, and reduced risk of infection.

Request Free Sample

Global Hemostats Market: Growth Factors

The hemostat clinical practice is growing very rapidly across the world thus anticipating boosting the global hemostats market growth. It offers lucrative growth opportunities for the market growth due to the presence of a pool of patients throughout the world. The affordable price of the tools expects to fuel the market growth. The surgical staple is the widely used tool to close the wounds. Topical hemostatic agents are broadly preferred as an alternative to standard suturing techniques in order to halt bleeding.

Hemostats Market: Report Scope

Global Hemostats Market: Segmentation

The global hemostats market is bifurcated on the basis of product type and region. The product type segment includes gelatin-based hemostats, thrombin-based, collagen-based hemostats, oxidized regenerated cellulose based hemostats, and combination hemostats.

Global Hemostats Market: Regional Analysis

North America is the leading consumer of the hemostats which is followed by Europe and Asia-Pacific region. Various strategies are adopted by the market players such as joint ventures, new product launches, agreements, partnerships, and collaborations in order to enhance the market revenue in the North America which contributes to the market growth. Increasing healthcare infrastructure coupled with rise in the number of surgeries is projected to propel the market in Europe. Asia-Pacific is the fastest growing region owing to increasing number of surgeries and change in regulatory policies encourages the market in the region. Other major factors propelling the global hemostats market growth are swift adoption of innovative products, early adoption of highly developed technologies, and improved healthcare facilities in the region.

Global Hemostats Market: Competitive Players

The key market players that are dominating the hemostats market include

• Anika Therapeutics Inc.
• C.R. Bard
• B. Braun Melsungen
• Pfizer
• 3-D Matrix Ltd.
• Medtrade Products Ltd.
• Stryker
• Baxter
• Integra Lifesciences Corporation
• Resorba Medical GmbH.
• Vascular Solutions Inc.
• Gamma Therapeutics Inc.
• Arch Therapeutics Inc.
• CSL Behring
• Equimedical
• B.V.
• Biom’Up SAS
• Medline Industries Inc.
• Hemostasis LLC
• CryoLife Inc.
• Mallinckrodt Plc.
• Hemostasis LLC
• and Hemotec Medical GmbH.

Segment By product type

• Gelatin-based hemostats
• Thrombin-based
• Collagen-based hemostats
• Oxidized regenerated cellulose based hemostats
• Combination hemostats

Global Hemostats Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa